Literature DB >> 16015684

Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation.

Ming-Ling Chang1, Chau-Ting Yeh, Pei-Yeh Chang, Jeng-Chang Chen.   

Abstract

AIM: To build up the research models of hepatic fibrosis in mice.
METHODS: Inbred wild-type FVB/N mice were either treated with alpha-naphthyl-isothiocyanate (ANIT), allyl alcohol (AA), carbon tetrachloride (CCl(4)), 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC), and silica, or subjected to common bile duct ligation (CBDL) to induce hepatic injury. Liver biopsies were performed every 4 wk to evaluate hepatic fibrosis over a period of 6 mo. Cumulative cirrhosis and survival curves were constructed by life table method and compared with Wilcoxon test.
RESULTS: Under the dosages used, there was neither mortality nor cirrhosis in AA and silica-treated groups. DDC and ANIT caused cirrhosis within 4-12 and 12-24 wk, respectively. Both showed significantly faster cirrhosis induction at high dosages without significant alteration of survival. The duration for cirrhosis induction by CCl(4) ranged from 4 to 20 wk, mainly dependent upon the dosage. However, the increase in CCl(4) dosage significantly worsened survival. Intraperitoneal CCl(4) administration resulted in better survival in comparison with gavage administration at high dosage, but not at medium and low dosages. After CBDL, all the mice developed liver cirrhosis within 4-8 wk and then died by the end of 16 wk.
CONCLUSION: CBDL and administrations of ANIT, CCl(4), and DDC ensured liver cirrhosis. CBDL required the least amount of time in cirrhosis induction, but caused shortened lives of mice. It was followed by DDC and ANIT administration with favorable survival. As for CCl(4), the speed of cirrhosis induction and the mouse survival depended upon the dosages and the administration route.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16015684      PMCID: PMC4615437          DOI: 10.3748/wjg.v11.i27.4167

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  Change in hepatic antioxidant defense system with liver injury development in rats with a single alpha-naphthylisothiocyanate intoxication.

Authors:  Y Ohta; M Kongo; E Sasaki; N Harada
Journal:  Toxicology       Date:  1999-12-06       Impact factor: 4.221

2.  Use of in vitro data for construction of a physiologically based pharmacokinetic model for naphthalene in rats and mice to probe species differences.

Authors:  D J Quick; M L Shuler
Journal:  Biotechnol Prog       Date:  1999 May-Jun

3.  Short-term toxicity of allyl alcohol in rats.

Authors:  F M Carpanini; I F Gaunt; J Hardy; S D Gangolli; K R Butterworth; A G Lloyd
Journal:  Toxicology       Date:  1978-02       Impact factor: 4.221

4.  Species differences in the regio- and stereoselectivity of 1-nitronaphthalene metabolism.

Authors:  K C Watt; A R Buckpitt
Journal:  Drug Metab Dispos       Date:  2000-04       Impact factor: 3.922

5.  Beneficial effect of nitric oxide synthase inhibitor on hepatotoxicity induced by allyl alcohol.

Authors:  K Alam; M N Nagi; O A Al-Shabanah; A M Al-Bekairi
Journal:  J Biochem Mol Toxicol       Date:  2001       Impact factor: 3.642

6.  Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

Authors:  N Sanderson; V Factor; P Nagy; J Kopp; P Kondaiah; L Wakefield; A B Roberts; M B Sporn; S S Thorgeirsson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

7.  Chirality of quartz. Fibrosis and tumour development in dust inoculated mice.

Authors:  P Ebbesen
Journal:  Eur J Cancer Prev       Date:  1991-10       Impact factor: 2.497

8.  FVB/N: an inbred mouse strain preferable for transgenic analyses.

Authors:  M Taketo; A C Schroeder; L E Mobraaten; K B Gunning; G Hanten; R R Fox; T H Roderick; C L Stewart; F Lilly; C T Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

9.  Toxicokinetics of inhaled 2-butoxyethanol and its major metabolite, 2-butoxyacetic acid, in F344 rats and B6C3F1 mice.

Authors:  J A Dill; K M Lee; D J Bates; D J Anderson; R E Johnson; B J Chou; L T Burka; J H Roycroft
Journal:  Toxicol Appl Pharmacol       Date:  1998-12       Impact factor: 4.219

10.  Activation of Proalpha2(I) collagen promoter during hepatic fibrogenesis in transgenic mice.

Authors:  Y Inagaki; S Truter; G Bou-Gharios; L A Garrett; B de Crombrugghe; T Nemoto; P Greenwel
Journal:  Biochem Biophys Res Commun       Date:  1998-09-29       Impact factor: 3.575

View more
  24 in total

1.  Imatinib mesylate improves liver regeneration and attenuates liver fibrogenesis in CCL4-treated mice.

Authors:  Wen-Ling Kuo; Ming-Chin Yu; Ju-Fang Lee; Chi-Neu Tsai; Tse-Ching Chen; Miin-Fu Chen
Journal:  J Gastrointest Surg       Date:  2011-11-09       Impact factor: 3.452

Review 2.  Cellular homeostasis and repair in the mammalian liver.

Authors:  Ben Z Stanger
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

3.  Lymphocytes contribute to biliary injury and fibrosis in experimental xenobiotic-induced cholestasis.

Authors:  Nikita Joshi; Anna K Kopec; Holly Cline-Fedewa; James P Luyendyk
Journal:  Toxicology       Date:  2016-12-31       Impact factor: 4.221

4.  Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes.

Authors:  Zhenyue Tong; Ruju Chen; Daniel S Alt; Sherri Kemper; Bernard Perbal; David R Brigstock
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

5.  Stress of Strains: Inbred Mice in Liver Research.

Authors:  Arlin B Rogers
Journal:  Gene Expr       Date:  2018-08-09

6.  Dose-dependent effects of alpha-naphthylisothiocyanate disconnect biliary fibrosis from hepatocellular necrosis.

Authors:  Nikita Joshi; Jessica L Ray; Anna K Kopec; James P Luyendyk
Journal:  J Biochem Mol Toxicol       Date:  2016-09-08       Impact factor: 3.642

Review 7.  Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.

Authors:  Michael Trauner; Peter Fickert; Emina Halilbasic; Tarek Moustafa
Journal:  Wien Med Wochenschr       Date:  2008

8.  Comparative Studies on Multi-Component Pharmacokinetics of Polygonum multiflorum Thunb Extract After Oral Administration in Different Rat Models.

Authors:  Ninghui Ma; Yong Zhang; Liyan Sun; Yuan Zhao; Yue Ding; Tong Zhang
Journal:  Front Pharmacol       Date:  2021-06-17       Impact factor: 5.810

Review 9.  Role of cholangiocytes in primary biliary cirrhosis.

Authors:  Ana Lleo; Luca Maroni; Shannon Glaser; Gianfranco Alpini; Marco Marzioni
Journal:  Semin Liver Dis       Date:  2014-07-24       Impact factor: 6.115

10.  Comparison of three research models of portal hypertension in mice: macroscopic, histological and portal pressure evaluation.

Authors:  Anja M Geerts; Eline Vanheule; Marleen Praet; Hans Van Vlierberghe; Martine De Vos; Isabelle Colle
Journal:  Int J Exp Pathol       Date:  2008-08       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.